These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 30617660)

  • 1. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing.
    Genina N; Boetker JP; Colombo S; Harmankaya N; Rantanen J; Bohr A
    J Control Release; 2017 Dec; 268():40-48. PubMed ID: 28993169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Obtain the Maximum Properties Flexibility of 3D Printed Ketoprofen Tablets Using Only One Drug-Loaded Filament?
    Pyteraf J; Jamróz W; Kurek M; Szafraniec-Szczęsny J; Kramarczyk D; Jurkiewicz K; Knapik-Kowalczuk J; Tarasiuk J; Wroński S; Paluch M; Jachowicz R
    Molecules; 2021 May; 26(11):. PubMed ID: 34067434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
    Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
    Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
    Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
    AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
    Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
    Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
    Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
    Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
    Gültekin HE; Tort S; Acartürk F
    Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate Release 3D-Printed Tablets Produced Via Fused Deposition Modeling of a Thermo-Sensitive Drug.
    Kempin W; Domsta V; Grathoff G; Brecht I; Semmling B; Tillmann S; Weitschies W; Seidlitz A
    Pharm Res; 2018 Apr; 35(6):124. PubMed ID: 29679157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of Taste-Masked Donut-Shaped Tablets Via Fused Filament Fabrication 3D Printing Paired with Hot-Melt Extrusion Techniques.
    Wang H; Dumpa N; Bandari S; Durig T; Repka MA
    AAPS PharmSciTech; 2020 Aug; 21(7):243. PubMed ID: 32856144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
    Obeid S; Madžarević M; Ibrić S
    Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
    Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
    Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
    Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
    Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction.
    Patel NG; Serajuddin ATM
    Int J Pharm; 2023 Feb; 632():122542. PubMed ID: 36566823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and Prediction.
    Korte C; Quodbach J
    AAPS PharmSciTech; 2018 Nov; 19(8):3333-3342. PubMed ID: 29855799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.